Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 11 - 20 of about 100   

Articles published

CBST 72.50 +1.15 (1.61%)
price chart
Cubist Pharmaceuticals Q3 14 Earnings Conference Call At 5:00 PM ET
(RTTNews.com) - Cubist Pharmaceuticals Inc ( CBST ) will host a conference call at 5:00 PM ETOctober 21, 2014, to discuss its Q3 14 earnings results.
Big Movers: MGM Resorts International (NYSE:MGM), Cubist Pharmaceuticals ...
Cubist Pharmaceuticals Inc. (NASDAQ:CBST) EVP Steven C. Gilman unloaded 48,125 shares of Cubist Pharmaceuticals stock on the open market in a transaction that occurred on Wednesday, October 1st.
Related articles »  
Whats Hot Today: MGM Resorts International (NYSE:MGM), Cubist ...
Cubist Pharmaceuticals Inc. (NASDAQ:CBST) announced that it will present new data from its antibiotics portfolio at IDWeek 2014, October 8-12, in Philadelphia, PA.
Related articles »  
Technical Data on Biotech Equities - Intrexon, Keryx Biopharma, Spectrum ...
Investor-Edge has initiated coverage on the following equities: Intrexon Corporation (NYSE: XON), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI), Sangamo BioSciences Inc. (NASDAQ: SGMO), and Cubist ...
Related articles »  
Trend Analysis Report � Tesoro Logistics LP (NYSE:TLLP), Cubist ...
Cubist Pharmaceuticals Inc (CBST) reported that results for the third quarter ended September 30, 2014. The Company will host a conference call and webcast today at 5:00 p.m.
Related articles »  
Insider Selling: Steven C. Gilman Sells 48125 Shares of Cubist Pharmaceuticals ...
Cubist Pharmaceuticals has a 52 week low of $58.50 and a 52 week high of $82.12. The stock has a 50-day moving average of $66.66 and a 200-day moving average of $67.44.
Related articles »  
News Round Up- ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Cubist ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) will launch its third quarter 2014 financial earnings as on Tuesday, October 21, 2014.
Related articles »  
Investors Alert: Oracle Corporation (NYSE:ORCL), Regeneron Pharmaceuticals ...
On 19 September Cubist Pharmaceuticals Inc. (NASDAQ:CBST) said it has opened up shop in Europe with a Swiss international headquarters, part of its plan to spend $400 million on infectious disease R&D this year and spotlight new treatments for global ...
Top News: Clovis Oncology (NASDAQ:CLVS), GT Advanced Technologies Inc ...
Cubist Pharmaceuticals Inc. (NASDAQ:CBST) EVP Steven C. Gilman sold 48,125 shares of the stock in a transaction dated Wednesday, October 1st.
Cubist's next CEO foresees 'evolution, not revolution' for the company
Cubist is recognized as a world leader in the development and commercialization of antibiotics, a field that's unlike any other in pharmaceuticals because of the slower ramp-up of sales and different standards for approval. Cubist's flagship drug for ...